We are delighted to welcome Xeraya Capital as an investor in All G®.
Xeraya is one of Asia’s premier life science investors: the only dedicated life sciences venture capital and private equity firm in Malaysia. Xeraya invests globally in the breakthroughs shaping the future of human health, deploying world-class biotechnology expertise reflected in a long track record of impactful investments.
Xeraya’s investment represents a vote of trust in All G’s mission and opens a meaningful pathway into South East Asia. Xeraya’s connections and capabilities are expected to accelerate All G’s access to commercialisation opportunities for our portfolio of recombinant bovine and human milk proteins, in some of the world’s fastest-growing nutrition and infant formula markets.
With this commitment, Xeraya Capital joins Savencia and existing investors Döhler Ventures, Agronomics Limited, and Ellerston Capital as part of our pre-Series B convertible note round.
“It is wonderful to have an investor like Xeraya onboard. The decision to back All G is a powerful endorsement of our science and our mission.” – Jan Pacas, CEO, All G
“We invest in transformative biology with a clear pathway to improving human health, and we’re excited to help All G expand into Southeast Asia and beyond.” – Fares Zahir, CEO, Xeraya Capita
